HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center.

AbstractPURPOSE:
To describe uveitis clinical characteristics in the elderly.
METHODS:
Retrospective review of 91 patients at the age of 60 or more years at the authors' uveitis tertiary center over a 7-year period.
RESULTS:
Uveitis in the elderly accounted for 30.1% of this population. Uveitis localization was anterior in 22.0% of patients, intermediate in 8.8%, posterior in 20.9%, while 41.7% patients presented with panuveitis. Sarcoidosis (37.4%) and idiopathic uveitis (36.3%) accounted for the majority of cases, whereas other diagnostic entities accounted for 26.3%. Panuveitis (41.7%) and sarcoidosis (37.4%) were detected at a significantly higher frequency than in the younger population. Contrarily, ankylosing spondylitis and established ophthalmological entities (pars planitis, Birdshot chorioretinopathy, Fuchs heterochromic cyclitis) were more common in patients younger than 60 years old.
CONCLUSION:
In the authors' experience, sarcoidosis is the leading cause of uveitis in the elderly. Idiopathic uveitis and other specific entities account for less than two-thirds of cases.
AuthorsMarie-Alix Grégoire, Laurent Kodjikian, Loig Varron, Jean-Daniel Grange, Christiane Broussolle, Pascal Seve
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) Vol. 19 Issue 4 Pg. 219-26 (Aug 2011) ISSN: 1744-5078 [Electronic] England
PMID21770796 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Steroids
Topics
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Chronic Disease
  • Female
  • Humans
  • Incidence
  • Male
  • Middle Aged
  • Panuveitis (epidemiology)
  • Retrospective Studies
  • Sarcoidosis (complications)
  • Steroids (therapeutic use)
  • Uveitis, Anterior (drug therapy, epidemiology, etiology)
  • Uveitis, Intermediate (drug therapy, epidemiology, etiology)
  • Uveitis, Posterior (drug therapy, epidemiology, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: